Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Muhammad Daniyal Afzal
Institution:
Kyrgyz State Medical Academy
Observed institution:
Kyrgyz State Medical Academy
ORCID:
0009-0000-6247-9385
Observed ORCID:
0009-0000-6247-9385
OpenAlex ID:
A5135063802
Sublingual Cyclobenzaprine Approval: Expanding Options for Fibromyalgia Management
2026
·
Muhammad Ali Abid
, Muhammad Hafi Abid
, et al.
·
Health Science Reports
·
1
FDA approves IcotydeTM (Icotrokinra): a novel IL-23 receptor antagonist for plaque psoriasis
2026
·
Muhammad Ali Abid
, Muhammad Hafi Abid
, et al.
·
Annals of Medicine and Surgery
·
1
Bridging pathogenesis and therapy in focal segmental glomerulosclerosis: the rise of dual receptor blockade with sparsentan
2026
·
Muhammad Ali Abid
, Muhammad Hafi Abid
, et al.
·
Annals of Medicine and Surgery
A paradigm shift in diabetes care: clinical implications of once-weekly insulin icodec
2026
·
Muhammad Ali Abid
, Muhammad Hafi Abid
, et al.
·
Annals of Medicine and Surgery
Yuvezzi™ (carbachol and brimonidine tartrate) dual-agent eyedrops: a new option for presbyopia
2026
·
Muhammad Ali Abid
, Muhammad Hafi Abid
, et al.
·
Annals of Medicine and Surgery
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type